| Previous close | 116.30 |
| Open | N/A |
| Bid | 89.10 |
| Ask | 106.00 |
| Strike | 360.00 |
| Expiry date | 2025-01-17 |
| Day's range | 116.30 - 116.30 |
| Contract range | N/A |
| Volume | |
| Open interest | 1 |
ZacksAmgen (AMGN) Up 5.8% Since Last Earnings Report: Can It Continue?
Amgen (AMGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ZacksBiogen's Phase II/III SMA Study for Higher Spinraza Dose Meets Goals
BIIB's pivotal mid to late-stage study evaluating a higher dosing regimen for Spinraza to treat SMA in infants meets the primary and secondary goals.
Investor's Business DailyIs Eli Lilly Stock A Buy After Slashing The Price Of Its New Weight-Loss Drug?
Eli Lilly halved the price of a new version of its weight-loss drug, Zepbound. Is Eli Lilly stock a buy right now?
© 2024 Yahoo. All rights reserved.